TITLE

Instability of Carbolith (lithium carbonate)

AUTHOR(S)
Misak, Aleksandra
PUB. DATE
January 2005
SOURCE
CMAJ: Canadian Medical Association Journal;1/18/2005, Vol. 172 Issue 2, p183
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Warns on the possible underdosing and relapse of patients with bipolar disorder as a result of the administration of Carbolith or lithium carbonate. Findings of clinical trials on the stability of Carbolith; Disease treated with lithium; Factors which affect the elimination of lithium from the body through the kidneys; Recommendations for physicians in monitoring the serum lithium concentration of patients who are taking Carbolith.
ACCESSION #
15619396

 

Related Articles

  • Pharmacokinetics of Lithium in Egyptian Bipolar Patients: Dosage Adjustment Approach. Abdel-Hameed Ibrahim Mohamed Ebid; Dina Awny Tawfik Abd-Allah; Mahmoud Mamdouh Mohamed Elhabiby // Pharmacology & Pharmacy;Apr2014, Vol. 5 Issue 4, p425 

    Due to its proven clinical effectiveness, lithium has been considered as a corner stone for the long-term treatment of Bipolar Disorder (BPD) for more than half a century. The objective of this study was to evaluate the effect of patients' different co-variables on lithium pharmacokinetics and...

  • Optimal dosing of medications. Maguire, Gerald A.; Phillips, Geoffrey // Journal of Family Practice;Mar2003 Supplement, Vol. 52 Issue 3, p22 

    This article aims at providing an optimal medication for the people suffering from bipolar disorder. Generally the treatment response for bipolar disorder is measured by seeing whether patients can get on with the life properly. It was observed that high and medium lithium dosages were...

  • Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study. Kraemer, Susanne; Minarzyk, Anette; Eppendorfer, Steffen; Henneges, Carsten; Hundemer, Hans-Peter; Wilhelm, Stefan; Grunze, Heinz // BMC Psychiatry;2013, Vol. 13 Issue 1, p1 

    Background: Although a range of pharmacotherapeutical options are available for the treatment of bipolar disorder, patient non-adherence to prescribed treatment regimens and early treatment discontinuation remain among the primary obstacles to effective treatment. Therefore, this observational...

  • Review: lithium reduces relapse rates in people with bipolar disorder. Geddes, J. R.; Burgess, S.; Hawton, K. // Evidence Based Mental Health;Aug2004, Vol. 7 Issue 3, p72 

    The article investigates whether lithium reduces relapse rates in people with bipolar disorder. The Cochrane Collaboration databases were used for this study. Randomised controlled trials (RCTs) of less than 3 months, comparing lithium with placebo for the maintenance of bipolar disorder were...

  • Tratamiento prolongado con litio del trastorno bipolar: revisión sistemática y metaanálisis de los ensayos controlados aleatorizados. Geddes, John R.; Burgess, Sally; Hawton, Keith; Jamison, Kay; Goodwin, Guy M. // American Journal of Psychiatry - Edición Española;May2004, Vol. 7 Issue 5, p277 

    No abstract available.

  • Family focused therapy is more effective than crisis management for preventing relapse after a bipolar episode. Miklowitz, D. J.; George, E. L.; Richards, J. A. // Evidence Based Mental Health;May2004, Vol. 7 Issue 2, p49 

    This article presents a study, which examines that for outpatients with a recent bipolar episode, whether family focused therapy reduce relapse and improve adherence to drug treatment. Concomitant drug therapy and other aspects of usual care were permitted in both groups as needed. Family...

  • Commentary. Zaretsky, Ari E. // Evidence Based Mental Health;May2004, Vol. 7 Issue 2, p49 

    The authors of this study have added to a recently burgeoning literature that attests to the feasibility and efficacy of manualised, psychosocial interventions as adjuncts to pharmocotherapy in the treatment of bipolar disorder. The authors are to be commended for conducting a randomised...

  • Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). Beech, R D; Leffert, J J; Lin, A; Sylvia, L G; Umlauf, S; Mane, S; Zhao, H; Bowden, C; Calabrese, J R; Friedman, E S; Ketter, T A; Iosifescu, D V; Reilly-Harrington, N A; Ostacher, M; Thase, M E; Nierenberg, A // Pharmacogenomics Journal;Apr2014, Vol. 14 Issue 2, p182 

    This study was designed to identify genes whose expression in peripheral blood may serve as early markers for treatment response to lithium (Li) in patients with bipolar disorder. Although changes in peripheral blood gene-expression may not relate directly to mood symptoms, differences in...

  • Lithium.  // Reactions Weekly;5/8/2004, Issue 1000, p11 

    Describes a case report on the side effects of the drug lithium on a patient with bipolar disorder. Development of lithium toxicity in the patient; Duration of drug use; Drug dosage taken by the patient.

  • Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics. Landersdorfer, Cornelia; Findling, Robert; Frazier, Jean; Kafantaris, Vivian; Kirkpatrick, Carl; Landersdorfer, Cornelia B; Findling, Robert L; Frazier, Jean A; Kirkpatrick, Carl M J // Clinical Pharmacokinetics;Jan2017, Vol. 56 Issue 1, p77 

    Background: Lithium is a well-established treatment for bipolar I disorder in adults. However, there is a paucity of information on its pharmacokinetics/pharmacodynamics in children and adolescents. We aimed to develop the first lithium dosage regimens based on population...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics